ANAPTYSBIO, INC (ANAB) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Medium Risk

Moderate dilution risk

Last updated: May 12, 2026

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 20.42% (2 years)

Historical Dilution Factor: moderate recent dilution

Outstanding Shares

29M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

ANAB currently has 28.7M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 20.42% over the past 2 years through share issuances.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
May 12, 2026	10-Q filing \| 28.7M shares outstanding	29M	0
Nov 04, 2025	10-Q filing \| 27.8M shares outstanding	28M	0
Aug 06, 2025	10-Q filing \| 28.8M shares outstanding	29M	0
May 05, 2025	10-Q filing \| 30.6M shares outstanding	31M	0
Feb 27, 2025	10-K filing \| 28.4M shares outstanding	28M	0
Nov 05, 2024	S-3 filing: The filing is an S-3 shelf registration allowing the company to offer common stock, preferred stock, debt securities, warrants, subscription rights and/or units up to a total of $500,000,000 from time to time.	27M	80K
Nov 05, 2024	10-Q filing \| 28.9M shares outstanding	29M	0
Aug 05, 2024	10-Q filing \| 27.4M shares outstanding	27M	80K
May 09, 2024	10-Q filing \| 26.8M shares outstanding	27M	640K
Mar 11, 2024	10-K filing \| 26.9M shares outstanding	27M	510K
Nov 02, 2023	10-Q filing \| 26.5M shares outstanding	27M	890K
Aug 07, 2023	10-Q filing \| 26.6M shares outstanding	27M	810K
May 11, 2023	10-Q filing \| 28.0M shares outstanding	28M	0
Mar 01, 2023	10-K filing \| 28.2M shares outstanding	28M	0
Nov 08, 2022	10-Q filing \| 28.3M shares outstanding	28M	0
Aug 08, 2022	10-Q filing \| 28.2M shares outstanding	28M	0
May 04, 2022	10-Q filing \| 27.7M shares outstanding	28M	0
Mar 07, 2022	10-K filing \| 27.4M shares outstanding	27M	5K
Dec 30, 2021	S-3 filing: AnaptysBio, Inc. files an S-3 form to offer Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units up to an aggregate amount of $300,000,000.	27M	0
Nov 04, 2021	10-Q filing \| 27.4M shares outstanding	27M	0
Aug 09, 2021	10-Q filing \| 27.4M shares outstanding	27M	0
May 04, 2021	10-Q filing \| 27.4M shares outstanding	27M	0
Feb 25, 2021	10-K filing \| 27.4M shares outstanding	27M	0
Nov 04, 2020	10-Q filing \| 27.3M shares outstanding	27M	0
Aug 10, 2020	10-Q filing \| 27.3M shares outstanding	27M	0
May 06, 2020	10-Q filing \| 27.3M shares outstanding	27M	0
Mar 02, 2020	10-K filing \| 26.9M shares outstanding	27M	0

Back to ANAB Details